INTERNATIONAL PATENT: ALKEUS PHARMACEUTICALS, INC. FILES APPLICATION FOR "GILDEURETINOL FOR USE FOR TREATING GEOGRAPHIC ATROPHY AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION"

GENEVA, March 11 -- ALKEUS PHARMACEUTICALS, INC. (44 Brattle St., 2nd FloorCambridge, Massachusetts 02138) filed a patent application (PCT/US2025/044210) for "GILDEURETINOL FOR USE FOR TREATING GEOGRAPHIC ATROPHY AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION" on Aug 29, 2025. With publication no. WO/2026/050657, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SAAD, Leonide C. (44 Brattle St., 2nd FloorCambridge, Massachusetts 02138), WASHINGTON, Ilyas (44 Brattle St., 2nd FloorCambridge, Massachusetts 02138)

Abstract:...